Evidence map›Paper›PMID 40615752›Full record

ArticleClinical journal of gastroenterology2025

First report of metabolic complete response in hepatic sarcomatoid carcinoma achieved with carbon-ion radiotherapy.

Ryu Takakura, Yoshiyuki Ota, Yuki Yamazaki, Satoru Iwamoto, Koki Kurouchi, Koki Moriyoshi, Shin'ichi Miyamoto

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ryu TakakuraDepartment of Gastroenterology, National Hospital Organization Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto, Japan.
Yoshiyuki OtaDepartment of Gastroenterology, National Hospital Organization Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto, Japan.
Yuki YamazakiDepartment of Gastroenterology, National Hospital Organization Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto, Japan.
Satoru IwamotoDepartment of Gastroenterology, National Hospital Organization Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto, Japan.
Koki KurouchiDepartment of Gastroenterology, National Hospital Organization Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto, Japan.
Koki MoriyoshiDepartment of Diagnostic Pathology, National Hospital Organization Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto, Japan.
Shin'ichi MiyamotoDepartment of Gastroenterology, National Hospital Organization Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto, Japan. shmiyamo@kuhp.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0003-2298-0970

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic sarcomatoid carcinoma (HSC) is a rare and highly aggressive subtype of primary liver cancer with no established treatment for unresectable cases. We report the case of a 71-year-old woman with unresectable HSC who achieved complete remission following carbon-ion radiotherapy. The patient exhibited a favorable response to primary tumor and lymph node metastases, with no recurrence observed after 17 months. This case highlights the potential efficacy of heavy-ion therapy as a promising alternative for managing HSC.

Indexed as

CarcinosarcomaHeavy Ion RadiotherapyLiver NeoplasmsAgedFemaleHumansLymphatic MetastasisRemission InductionHeavy-ion therapyHepatic sarcomatoid carcinomaMetabolic complete responseUnresectable

Identifiers

PMID40615752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.